Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-037938
Filing Date
2019-10-25
Accepted
2019-10-25 17:03:51
Documents
6
Period of Report
2019-12-10
Effectiveness Date
2019-10-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A abio-def14a_20191028.htm DEF 14A 801963
2 GRAPHIC g2j4ofopxz2c000002.jpg GRAPHIC 2919
3 GRAPHIC g2j4ofopxz2c000003.jpg GRAPHIC 2919
4 GRAPHIC g2j4ofopxz2c000005.jpg GRAPHIC 45541
5 GRAPHIC g2j4ofopxz2c000001.jpg GRAPHIC 2919
6 GRAPHIC g2j4ofopxz2c000004.jpg GRAPHIC 69884
  Complete submission text file 0001564590-19-037938.txt   974992
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22873 | Film No.: 191170612
SIC: 2835 In Vitro & In Vivo Diagnostic Substances